Verastem Oncology Competitors and Similar CompaniesClear all
Verastem Oncology's competitors and similar companies include Tanvex BioPharma, Novartis and InxMed.
 Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  InxMed InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines. | |
Founding Date | Founding Date 2010 | Founding Date 2013 | Founding Date 1996 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Needham, US HQ Walsrode, DE | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations HQ |
Employees | Employees 7328% increase | Employees 13827% decrease | Employees 75,883 | Employees 17 |
Financial | ||||
Revenue (est.) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) NT$401m (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods NT$466.3m (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit (NT$10.6m) (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit N/A |
Net income | Net income ($209.5m) (FY, 2025) | Net income (NT$1.5b) (FY, 2025) | Net income $14b (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Phase I/II Trials Products | Phase I/II Trials Products 6 (FY, 2020) | Phase I/II Trials Products N/A | Phase I/II Trials Products 100 (FY, 2022) | Phase I/II Trials Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 170m | Total funding raised $ 346.9m | Total funding raised $ 6.5m | Total funding raised $ 19m |
For sources of this data, please see the company profile
View Company Profiles
Tanvex BioPharma
HQ
Taipei, TW
Employees
138↓ 27% decrease
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyInxMed
HQ
Employees
17
InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines.
View company